tm
Seeing Is Believing
tm
Seeing Is Believing
SGMO is currently covered by 7 analysts with an average potential upside of $5.58 (92.49%) from yesterday's end of day stock price of $0.49. Sangamo Therapeutics activity chart has currently 9 price targets and 30 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 225 days.
Highest price target for SGMO is $7, Lowest price target is $7, average price target is $7.
Most recent stock forecast was given by NICOLE GERMINO from TRUIST on 07-Nov-2023. First documented stock forecast 18-May-2015.
Currently, out of the existing stock ratings of SGMO - 12 which are a Buy (66.67%), 6 which are a Hold (33.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 months 2 days ago
0/1 (0%)
$11.48 (109.13%)
Buy
1
$0.51 (104.08%)
1 months 3 days ago
1/3 (33.33%)
$6.32 (92.30%)
980
Buy
2
$1.51 (308.16%)
1 months 6 days ago
0/2 (0%)
$5.96 (211.98%)
Buy
4
3 months 28 days ago
1/2 (50%)
$1.38 (43.79%)
53
Hold
4.4
3 months 29 days ago
1/1 (100%)
$0.26 (6.28%)
60
What is SGMO (Sangamo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SGMO (Sangamo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SGMO (Sangamo Therapeutics)?
Which analyst is the currently most bullish on SGMO (Sangamo Therapeutics)?
Which analyst is the currently most reserved on SGMO (Sangamo Therapeutics)?
